Key Market Indicators
The country was number 4 in 2021, France with $178,070,000. France, Spain and Italy respectively ranked numbers 2, 3 and 4 in this ranking. Sales of diabetes medicines in Italy are set to reach $1.44 billion by 2026, a 1.4% year-on-year growth. Since 2016, the market has increased by 6.4% annually. In 2021, Italy ranked fourth, behind Spain ($1.35 billion). Canada, Spain and Italy took the top three spots. Italian insulin exports are forecast to hit $1.18 billion by 2026, a 3.6% annual growth rate. Since 1999, supplies have risen 13% annually. In 2021, Italy placed third, behind France ($949.54 million). France, Italy and China held the top three spots. Italian insulin imports, meanwhile, are set to total $163.18 million by 2026, a 1.1% year-on-year decline. Since 1999, demand has fallen 4% annually. In 2021, France led the way with $178.07 million. France, Spain and Italy took the top three spots.
